rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-3-1
|
pubmed:abstractText |
The use of sirolimus-eluting coronary stents has been associated with a nearly complete elimination of restenosis at 6 months and with a very low 1-year incidence of major adverse cardiac events (MACE). This analysis examined whether these beneficial effects persist over the longer term.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4539
|
pubmed:author |
pubmed-author:Ban HayashiErnestoE,
pubmed-author:BarraganPaulP,
pubmed-author:BartorelliAntonioA,
pubmed-author:BlanchardDidierD,
pubmed-author:BodeChristophC,
pubmed-author:ColomboAntonioA,
pubmed-author:ConstantiniConstantino RCR,
pubmed-author:EltchaninoffHélèneH,
pubmed-author:FajadetJeanJ,
pubmed-author:GuagliumiGiulioG,
pubmed-author:GuermonprezJean-LéonJL,
pubmed-author:LaarmanGert-JanGJ,
pubmed-author:MolnarFerencF,
pubmed-author:MoriceMarie-ClaudeMC,
pubmed-author:PerinMarcoAntonioM,
pubmed-author:SchulerGerhardG,
pubmed-author:SerruysPatrick WPW,
pubmed-author:SousaJ EduardoJE,
pubmed-author:WülfertEgonE,
pubmed-author:WijnsWilliamW
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1040-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15723977-Coronary Restenosis,
pubmed-meshheading:15723977-Coronary Stenosis,
pubmed-meshheading:15723977-Coronary Vessels,
pubmed-meshheading:15723977-Double-Blind Method,
pubmed-meshheading:15723977-Female,
pubmed-meshheading:15723977-Follow-Up Studies,
pubmed-meshheading:15723977-Humans,
pubmed-meshheading:15723977-Male,
pubmed-meshheading:15723977-Middle Aged,
pubmed-meshheading:15723977-Myocardial Revascularization,
pubmed-meshheading:15723977-Sirolimus,
pubmed-meshheading:15723977-Stents,
pubmed-meshheading:15723977-Time
|
pubmed:year |
2005
|
pubmed:articleTitle |
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
|
pubmed:affiliation |
Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France. fajadet@interv-cardiol-toul.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|